bioMerieux is a corporate venture arm. Based in Marcy-l'Étoile, France. Known portfolio companies include Quanterix, Oxford Nanopore Technologies, Plair, Accunome, AdvanDx and Allergen Alert, 10 companies in all.
Is bioMerieux a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- HardwareHealthcare
- Focus
- BiotechDiagnosticsGenomicsIn Vitro DiagnosticsMedTechMedical Devices
bioMerieux portfolio companies (10)
- Quanterix
- Oxford Nanopore Technologies
- Plair
- Accunome
- AdvanDx
- Allergen Alert
- InDevR
- Accellix
- Proxim Diagnostics
- Qvella Corporation
Co-investors
Funds that share portfolio companies with bioMerieux.
Similar funds
Showing 20 of 100
About bioMerieux
The firm's listing covers sectors Hardware and Healthcare, and focus areas Biotech, Diagnostics, Genomics and In Vitro Diagnostics; known deals cluster at Series A and Series B.
Across the known portfolio, 12 co-investors appear alongside bioMerieux, including Bluehill.VC, Chuang House Capital 创瓴资本 and Chuang House Capital 创瓴资本.
Frequently asked questions
What is bioMerieux?
bioMerieux is a corporate venture arm based in Marcy-l'Étoile, France, with a known portfolio of 10 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does bioMerieux invest in?
Listed sectors include Hardware and Healthcare; listed focus areas include Biotech, Diagnostics, Genomics and In Vitro Diagnostics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does bioMerieux invest at?
The known deals of bioMerieux include Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact bioMerieux?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal